NCT06286488View on ClinicalTrials.gov

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

August 23, 2023

Study Completion Date

May 1, 2026

Conditions
InfluenzaObesityPregnancy; InfectionElderly InfectionVaccine ReactionVaccine Adverse ReactionTolerance
Interventions
DRUG

Vaxigrip

Evaluation of immunogenicity and tolerance of quadrivalent influenza vaccine in groups at risk of severe influenza, including obese adults, as well as in pregnant women (with assesment of antibodies in cord blood).

Trial Locations (1)

02-077

Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER